Microbiota-Driven Mechanisms in Endometrial Cancer Pathogenesis: Focus on Lynch Syndrome

Lynch syndrome is the most common hereditary syndrome predisposing to endometrial cancer, but the mechanisms contributing to tumor development remain incompletely understood. This review aimed to summarise current evidence on the composition and potential pathogenic role of the microbiota in Lynch syndrome-associated endometrial cancer and to explore its clinical implications. A systematic literature search of PubMed/MEDLINE and Embase was conducted between October and November 2025 using predefined terms related to microbiota, carcinogenesis, endometrial cancer, and Lynch syndrome. Available evidence suggests that alterations in the microbiota may contribute to carcinogenesis through chronic inflammation, immune modulation, metabolic changes, and bacterial genotoxicity. Studies in Lynch syndrome carriers with endometrial or colorectal cancer report an increased abundance of potentially pro-inflammatory Gram-negative bacteria, including Bacteroides fragilis and Fusobacterium nucleatum, together with a reduction in short-chain fatty acid-producing bacteria such as Faecalibacterium, Blautia, and Butyrivibrio. Microbial metabolites, including butyrate, may have protective effects, whereas bacterial β-glucuronidase activity may increase estrogen bioavailability and contribute to a tumor-promoting environment. Emerging evidence also suggests that the microbiota may influence treatment response and toxicity. Overall, current evidence supports a potential role for the microbiota in Lynch syndrome-associated endometrial carcinogenesis, although data remain limited. Further studies are needed to determine whether microbiota profiling could contribute to risk stratification, prevention, and personalized therapeutic strategies.

Authors

Institutions

Publication Details

Journal
Current Oncology
Published
2026-11-17
DOI
https://doi.org/10.3390/curroncol33110710
Primary Topic
Gut microbiota and health
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Microbiota-Driven Mechanisms in Endometrial Cancer Pathogenesis: Focus on Lynch Syndrome

Luca Pace, Annamaria Ferrero, Marta D’Alonzo, Valentina Elisabetta Bounous et al.
1 links
Current Oncology
Gut microbiota and health
article

Microbiota-Driven Mechanisms in Endometrial Cancer Pathogenesis: Focus on Lynch Syndrome

Luca Pace, Annamaria Ferrero, Marta D’Alonzo, Valentina Elisabetta Bounous, Margherita Giorgi, Silvia Actis, Gaetano Perrini, Beatrice Campigotto, Massimiliano Cazzaniga, Maria Pascotto
article en

Abstract

Lynch syndrome is the most common hereditary syndrome predisposing to endometrial cancer, but the mechanisms contributing to tumor development remain incompletely understood. This review aimed to summarise current evidence on the composition and potential pathogenic role of the microbiota in Lynch syndrome-associated endometrial cancer and to explore its clinical implications. A systematic literature search of PubMed/MEDLINE and Embase was conducted between October and November 2025 using predefined terms related to microbiota, carcinogenesis, endometrial cancer, and Lynch syndrome. Available evidence suggests that alterations in the microbiota may contribute to carcinogenesis through chronic inflammation, immune modulation, metabolic changes, and bacterial genotoxicity. Studies in Lynch syndrome carriers with endometrial or colorectal cancer report an increased abundance of potentially pro-inflammatory Gram-negative bacteria, including Bacteroides fragilis and Fusobacterium nucleatum, together with a reduction in short-chain fatty acid-producing bacteria such as Faecalibacterium, Blautia, and Butyrivibrio. Microbial metabolites, including butyrate, may have protective effects, whereas bacterial β-glucuronidase activity may increase estrogen bioavailability and contribute to a tumor-promoting environment. Emerging evidence also suggests that the microbiota may influence treatment response and toxicity. Overall, current evidence supports a potential role for the microbiota in Lynch syndrome-associated endometrial carcinogenesis, although data remain limited. Further studies are needed to determine whether microbiota profiling could contribute to risk stratification, prevention, and personalized therapeutic strategies.

Current OncologyVol. 33(11)
Velleja Research (IT), A. O. Ordine Mauriziano di Torino (IT), Candiolo Cancer Institute (IT), University of Turin (IT)
Good health and well-being
Gut microbiota and health
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon